Access to anti-retroviral drugs, male in Latvia
Latvia: Access to anti-retroviral drugs, male was 51.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Latvia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Latvia stood at 51.0%. That is the highest value across all 25 years on record.
The figure is up 2.0% on the previous year and up 240.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Latvia peaked at 51.0% in 2024 and was at its lowest, 1.0%, in 2000.
That places Latvia 116th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Latvia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 1.0% | +0.0% |
| 2002 | 2.0% | +100.0% |
| 2003 | 2.0% | +0.0% |
| 2004 | 2.0% | +0.0% |
| 2005 | 2.0% | +0.0% |
| 2006 | 3.0% | +50.0% |
| 2007 | 6.0% | +100.0% |
| 2008 | 6.0% | +0.0% |
| 2009 | 8.0% | +33.3% |
| 2010 | 9.0% | +12.5% |
| 2011 | 11.0% | +22.2% |
| 2012 | 12.0% | +9.1% |
| 2013 | 13.0% | +8.3% |
| 2014 | 15.0% | +15.4% |
| 2015 | 16.0% | +6.7% |
| 2016 | 28.0% | +75.0% |
| 2017 | 34.0% | +21.4% |
| 2018 | 40.0% | +17.6% |
| 2019 | 45.0% | +12.5% |
| 2020 | 47.0% | +4.4% |
| 2021 | 48.0% | +2.1% |
| 2022 | 49.0% | +2.1% |
| 2023 | 50.0% | +2.0% |
| 2024 | 51.0% | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.3% | 1.0% | 8.0% | 10 |
| 2010s | 22.3% | 9.0% | 45.0% | 10 |
| 2020s | 49.0% | 47.0% | 51.0% | 5 |
Countries ranked near Latvia
More gender data for Latvia
- Child population (UN estimates and projections) 242.79 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -3.87 % change on previous year (2030)
- Population 1,535 (2030)
- Working-age population (UN estimates and projections) 1,535 (2030)
- Population (UN estimates and projections), annual growth rate -0.3312 % change on previous year (2030)
- Age population, age 00, female, interpolated 6,644 (2025)
- Age population, age 00, male, interpolated 7,068 (2025)
- Age population, age 01, female, interpolated 6,775 (2025)
- Age population, age 01, male, interpolated 7,216 (2025)
- Age population, age 02, female, interpolated 7,299 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Latvia?
- Access to anti-retroviral drugs, male in Latvia was 51.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Latvia?
- The highest recorded value was 51.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Latvia?
- The lowest recorded value was 1.0% in 2000.
- How does Latvia rank for access to anti-retroviral drugs, male?
- Latvia ranks 116th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Latvia?
- Over the last ten years it is up 240.0%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.